GeneDx Holdings Corp reports results for the quarter ended in January - Earnings Summary

GeneDx Holdings

30/04/2024 02:46

* GeneDx Holdings Corp  WGS.OQ  reported a quarterly
adjusted loss
of 33 cents​​ per share for the quarter ended in January, higher
than the same quarter last year, when the company reported EPS
of $-2.44.  The mean expectation of four analysts for the
quarter was for a loss of 67 cents per share. Wall Street
expected results to range from -75 cents to -57 cents per share.
    * Revenue rose 41.6% to $61.10 million from a year ago;
analysts
expected $49.46 million. 
    * GeneDx Holdings Corp's reported EPS for the quarter was a
loss
of 78 cents​.
    * The company reported a quarterly loss of $20.24 million.
    * GeneDx Holdings Corp shares had risen by 21.4% this
quarter and
gained 302.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 11.1%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the healthcare
facilities & services peer group is also "buy"

Wall Street's median 12-month price target for GeneDx Holdings
Corp is $12.50 
This summary was machine generated from LSEG data April 30 at
01:46 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.67          -0.33          Beat
 Dec. 31 2023      -0.75          -0.69          Beat
 Sep. 30 2023      -1.31          -0.82          Beat
 Jun. 30 2023      -1.31          -1.64          Missed